长链非编码RNA LOC102639982和LOC102636309与自身免疫性肝炎肝损伤的关联OACSTPCD
Association of long non-coding RNA LOC102639982 and LOC102636309 with liver injury in autoimmune hepatitis
目的 探讨差异表达长链非编码RNA(lncRNA)LOC102639982和lncRNA LOC102636309参与自身免疫性肝炎肝损伤的生物学机制.方法 选取SPF级雌性C57BL/6小鼠12只,随机分为正常组和模型组.模型组采用尾静脉注射刀豆蛋白A(concanavalin A,ConA)制备自身免疫性肝炎(autoimmune hepatitis,AIH)小鼠模型,正常组注射生理盐水.收集各组小鼠的肝脏和血清,采用HE染色观察肝细胞坏死程度和肝脏炎症细胞浸润程度,ELISA法检测血清谷丙转氨酶(ALT)、谷草转氨酶(AST)、一氧化氮(NO)和丙二醛(MDA)含量的变化.qRT-PCR检测lncRNA LOC102639982和lncRNA LOC102636309在肝脏中的表达水平,并对两种lncRNA共表达的mRNA进行GO和KEGG富集分析以及lncRNA-转录因子关联分析.结果 HE染色结果显示,模型组小鼠肝细胞变性坏死,出现大量炎性细胞浸润.与正常组比较,模型组小鼠肝组织NO、MDA水平及血清ALT、AST水平均显著升高(P<0.01).qRT-PCR 结果显示,lncRNA LOC102639982和lncRNA LOC102636309表达变化的结果与微阵列芯片的表达趋势一致.qRT-PCR结果结合肝损伤结果表明,微阵列芯片的结果变化趋势与肝损伤指标变化趋势一致.生物信息学研究结果表明,lncRNA LOC102639982和lncRNA LOC102636309共表达的mRNA的主要分子功能是蛋白结合,主要富集在生物过程中的转录调控、DNA模板化.与lncRNA LOC102639982共表达的mRNA主要富集于细胞因子与细胞因子受体相互作用和TNF信号通路,而与lncRNA LOC102636309共表达的mRNA主要富集于MAPK和NF-kappa B信号通路.lncRNA LOC102639982与转录因子NR4A1和ATF3的相关性最强,而lncRNA LOC102636309与转录因子Fosl2的相关性最强.结论 lncRNA LOC102639982和lncRNA LOC102636309的差异表达与自身免疫性肝炎肝损伤密切相关,两者均可能是预防和治疗自身免疫性肝炎的潜在靶点.
Objective To investigate the biological mechanisms of differentially expressed long non-coding RNA(lncRNA)LOC102639982 and lncRNA LOC102636309 in the development of autoimmune hepatitis(AIH).Methods Twelve SPF grade female C57BL/6 mice were randomly divided into normal group and model group.The mice in model group were injected with concanavalin A(ConA)in the tail vein to prepare the mouse model of AIH,and the mice in normal group were injected with normal saline.The liver and serum of mice in each group were collected.The necrosis degree of hepatocytes and the infiltration degree of liver inflammatory cells were observed by HE staining.The contents of alanine aminotransferase(ALT),aspartate aminotransferase(AST),nitric oxide(NO)and malondialdehyde(MDA)in serum were detected by ELISA.The expression levels of lncRNA LOC102639982 and lncRNA LOC102636309 in liver were detected by qRT-PCR,GO and KEGG enrichment analysis and lncRNA-transcription factor association analysis were performed on the mRNA co-expressed by the two lncRNAs.Results HE staining showed that the hepatocytes in model group were degenerated and necrotic,with a large number of infiltrated inflammatory cells.Compared with normal group,the levels of NO and MDA in liver tissues and the serum ALT and AST levels were significantly increased in model group(P<0.01).Changes of lncRNA LOC102639982 and lncRNA LOC102636309 expression by qRT-PCR were consistent with the results of microarray chip.The results of qRT-PCR combined with the results of liver injury showed that the change trend of microarray chip results was consistent with that of liver injury indexes.The bioinformatics results showed that the mRNAs co-expressed by lncRNA LOC102639982 and lncRNA LOC102636309 were mainly enriched in protein binding in molecular function,and mainly enriched in transcriptional regula-tion and DNA templateization in biological processes.The mRNAs co-expressed with lncRNA LOC102639982 were mainly enriched in cytokine and cytokine receptor interaction and TNF signaling pathways,while the mRNAs co-expressed with lncRNA LOC102636309 were mainly enriched in MAPK and NF-kappa B signaling pathways.LncRNA LOC102639982 was most strongly associated with the transcription factors NR4A1,ATF3,while lncRNA LOC102636309 was most strongly associated with the transcription factor Fols2.Conclusion The differential expressions of lncRNA LOC102639982 and lncRNA LOC102636309 are strongly correlated with autoim-mune hepatitis liver injury,and both may be potential targets for the prevention and treatment of autoimmune hepatitis.
吕思学;刘莹;李鑫;魏诗雅;蔡粉情;刘杨
山西中医药大学基础医学院,晋中 030619
临床医学
自身免疫性肝炎长链非编码RNAGO分析KEGG富集分析lncRNA转录因子关联分析
autoimmune hepatitislong non-coding RNAGO analysisKEGG enrichment analysislncRNAtranscription factor association analysis
《山西医科大学学报》 2024 (009)
1154-1162 / 9
国家中医药管理局高水平中医药重点学科建设项目(zyyzdxk-2023022);中西医结合防治风湿免疫病山西省科技创新人才重点团队项目(202204051002033);山西省科技合作交流专项重点国别科技合作项目(202104041101013);山西省应用基础研究计划青年科学基金项目(202203021222272);山西省中医药管理局科研课题计划项目(2024ZYYAD008);山西中医药大学科技创新团队项目(2022TD2003)
评论